PL3991795T3 - Nowe zastosowanie mononukleotydu nikotynamidu (nmn) i rybozydu nikotynamidu (nr) - Google Patents

Nowe zastosowanie mononukleotydu nikotynamidu (nmn) i rybozydu nikotynamidu (nr)

Info

Publication number
PL3991795T3
PL3991795T3 PL20832373.3T PL20832373T PL3991795T3 PL 3991795 T3 PL3991795 T3 PL 3991795T3 PL 20832373 T PL20832373 T PL 20832373T PL 3991795 T3 PL3991795 T3 PL 3991795T3
Authority
PL
Poland
Prior art keywords
nicotinamide
nmn
new use
mononucleotide
riboside
Prior art date
Application number
PL20832373.3T
Other languages
English (en)
Polish (pl)
Inventor
Masao Doi
Takeshi Nakajima
Mamiko Machida
Original Assignee
Senju Pharmaceutical Co., Ltd.
Kyoto University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co., Ltd., Kyoto University filed Critical Senju Pharmaceutical Co., Ltd.
Publication of PL3991795T3 publication Critical patent/PL3991795T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL20832373.3T 2019-06-25 2020-06-24 Nowe zastosowanie mononukleotydu nikotynamidu (nmn) i rybozydu nikotynamidu (nr) PL3991795T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019117642 2019-06-25
PCT/JP2020/024916 WO2020262497A1 (ja) 2019-06-25 2020-06-24 ニコチンアミドモノヌクレオチド(nmn)およびニコチンアミドリボシド(nr)の新規用途

Publications (1)

Publication Number Publication Date
PL3991795T3 true PL3991795T3 (pl) 2025-01-13

Family

ID=74060627

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20832373.3T PL3991795T3 (pl) 2019-06-25 2020-06-24 Nowe zastosowanie mononukleotydu nikotynamidu (nmn) i rybozydu nikotynamidu (nr)

Country Status (7)

Country Link
US (1) US20220370484A1 (https=)
EP (1) EP3991795B1 (https=)
JP (1) JP7572007B2 (https=)
CN (1) CN114007693B (https=)
ES (1) ES2989969T3 (https=)
PL (1) PL3991795T3 (https=)
WO (1) WO2020262497A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119792334A (zh) * 2025-02-25 2025-04-11 中国农业大学 组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2609549A1 (en) * 2005-05-25 2006-11-30 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
EP2968306B1 (en) * 2013-03-15 2023-06-07 Washington University Administration of nicotinamide mononucleotide in the treatment of dry eye
JP2018100222A (ja) * 2015-04-20 2018-06-28 学校法人慶應義塾 角膜損傷の治療剤、改善剤または予防剤
CA3288232A1 (en) * 2015-10-23 2025-11-29 Jackson Lab Nicotinamide is used in the treatment and prevention of neurodegenerative eye disorders (for example, glaucoma).
US20170326161A1 (en) * 2015-12-10 2017-11-16 Imprimis Pharmaceuticals, Inc. Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof
WO2018052019A1 (ja) * 2016-09-13 2018-03-22 めぐみ 田中 視覚機能改善剤及び視覚機能の改善方法
KR20210153027A (ko) * 2018-09-14 2021-12-16 메구미 타나카 노화방지제 및 노화방지방법
JP6831407B2 (ja) 2019-02-22 2021-02-17 能美防災株式会社 火災受信機

Also Published As

Publication number Publication date
EP3991795A1 (en) 2022-05-04
US20220370484A1 (en) 2022-11-24
WO2020262497A1 (ja) 2020-12-30
CN114007693A (zh) 2022-02-01
EP3991795B1 (en) 2024-09-11
JPWO2020262497A1 (https=) 2020-12-30
JP7572007B2 (ja) 2024-10-23
ES2989969T3 (es) 2024-11-28
CN114007693B (zh) 2024-07-12
EP3991795A4 (en) 2023-07-19

Similar Documents

Publication Publication Date Title
ECSP20028090A (es) Ligandos de integrina y usos de estos
CL2020000060A1 (es) Compuestos antiproliferativos y métodos para utilizarlos.
DK3331894T3 (da) Nicotinamidmononukleotidderivater og anvendelser deraf
IL286481A (en) Pyridazinones and methods of use thereof
TWD196765S (zh) 手鐲
HRP20251095T1 (hr) Neoantigeni i metode njihove uporabe
TWD181578S (zh) 手鍊
EP4234561C0 (en) Antiviral prodrugs and nanoformulations thereof
TWD181260S (zh) 耳環
IL281438A (en) Pyridazinones and methods of use thereof
TWD177948S (zh) 垂飾
TWD178825S (zh) 項鍊
IL280809B (en) Novel compositions, their use, and methods for their formation
EP3535914C0 (en) DECOUPLING OF SYNCHRONIZATION CHANNEL GRID AND CHANNEL GRID
IL288310A (en) Cot modulators and methods of use thereof
TWD176022S (zh) 項鍊
IL286620A (en) T cell receptors and methods of use thereof
HUE064244T2 (hu) Módszerek szklerózis multiplex kezelésére BTK gátló aktivitású pirimidin- és piridin-származékokkal
IL281420A (en) Deuterium-enriched pirfenidone and methods of use thereof
IL290297A (en) Modified cytotoxic t cells and methods of use thereof
PL3710036T3 (pl) Stabilne kompozycje kwasu askorbinowego i sposoby ich zastosowania
TWD186440S (zh) 階梯模擬器
IL286037A (en) T cell receptors and methods of use thereof
KR102404611B9 (ko) 짧은 시퀀스 신호의 그룹화 및 사용
IL286032A (en) T cell receptors and methods of use thereof